Prime Therapeutics VP of Finance Salaries in Minneapolis | Comparably
Prime Therapeutics Claimed Company
Prime Therapeutics is an independent pharmacy benefit manager that primarily serves Blue Cross Blue Shield plans read more
EMPLOYEE
PARTICIPANTS
53
TOTAL
RATINGS
422
HR or Marketing? Claim Your Free Employer Account

Prime Therapeutics VP of Finance Salaries in Minneapolis

The average Prime Therapeutics VP of Finance in Minneapolis earns an estimated $166,217 annually. Prime Therapeutics' VP of Finance compensation is $40,313 less than the US average for a VP of Finance.

In Minneapolis, The Finance Department at Prime Therapeutics earns $4,357 more on average than the IT Department.

Last updated a year ago.

$50k
$90k
$145k
$200k
$309k
$430k
$518k
$166,217
Average Compensation
$166,217
avg. base

VP of Finance Salaries at Prime Therapeutics

In Minneapolis, VPs of Finance earn $51,147 more than Accounting Managers.

Accounting Manager
$115k*
Senior Accountant
$85k*
Accountant
$68k*
Financial Analyst
$64k*
* estimated salary

Compensation at Prime Therapeutics by Department

In Minneapolis, The Finance Department averages $4,357 more than the IT Department, and $3,562 less than the HR Department

HR
$91,752 Avg. total comp.
+$4k
Finance
$88,190 Avg. total comp.
IT
$83,833 Avg. total comp.
-$4k

VP of Finance Compensation by Gender (All Companies)

The average female VP of Finance at companies similar size to Prime Therapeutics reported making $231,000, while the average male VP of Finance at similar sized companies reported making $214,467.

VP of Finance Compensation by Ethnicity (All Companies)

The average Caucasian VP of Finance at companies similar size to Prime Therapeutics reported making $223,611, while the average Asian or Pacific Islander VP of Finance at similar sized companies reported making $176,500.

How VPs of Finance at Prime Therapeutics Rate Their Compensation

The majority of VPs of Finance at Prime Therapeutics believe they're compensated fairly. 100% of VPs of Finance at Prime Therapeutics say they receive annual bonuses, and the vast majority (77%) are satisfied with their benefits. See more compensation ratings at Prime Therapeutics

×
Rate your company